NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / 72-year-old COVID-19 patient given 'antibody cocktail' in Mohali
    India

    72-year-old COVID-19 patient given 'antibody cocktail' in Mohali

    72-year-old COVID-19 patient given 'antibody cocktail' in Mohali
    Written by Astha Oriel
    (PTI desk)
    May 31, 2021, 03:11 pm 3 min read
    72-year-old COVID-19 patient given 'antibody cocktail' in Mohali
    Roche's Antibody Cocktail is priced at Rs. 59,750 per dose

    A 72-year-old COVID-19 positive man was administered the monoclonal antibody cocktail therapy at Fortis Hospital in Mohali on Sunday, days after the treatment was given to two similar patients in Delhi and Gurgaon hospitals. The Mohali-based Fortis Hospital, in a statement, said that the patient, who had tested positive for COVID-19 infection two days ago, is a diabetic with chronic kidney disease.

    Monoclonal antibodies are artificially generated in the lab

    "He was administered one dose of the cocktail intravenously," the statement said, adding that the patient is stable after the infusion. Dr. Zafar Ahmed, a senior consultant with the Critical Care, Pulmonology and Chest and Sleep Medicine Department of the Mohali Fortis Hospital, said, "Like antibodies, which are proteins generated by the body to fight disease, monoclonal antibodies are artificially created in the lab."

    'Therapy is an important step toward combatting the pandemic'

    "In this cocktail, Casirivimab and Imdevimab are monoclonal antibodies that specifically block the spike protein of SARS-CoV-2 virus, thereby preventing the coronavirus attachment and entry into human cells," said Dr. Ahmed. "This is another very important step that has been taken by the medical community to effectively combat the pandemic and help people recover faster," he added.

    Roche India and Cipla had launched cocktail last week

    Drug majors Roche India and Cipla had on Monday announced the launch of Roche's Antibody Cocktail in India, priced at Rs. 59,750 per dose for the treatment of mild to moderate COVID-19 patients facing high risks.

    Currently available one lakh packs can benefit two lakh patients

    Cipla and Roche had said in a joint statement, "The first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June." "In total, they can potentially benefit 2,00,000 patients as each of the 1,00,000 packs that will be available in India offers treatment for two patients," the statement added.

    It has also received EUA in US, several EU countries

    As per the statement, Cipla will distribute the product by leveraging its strong distribution strengths across the country and the drug will be available through leading hospitals and COVID-19 treatment centers. The Central Drugs Standards Control Organisation (CDSCO) had recently provided an emergency use authorization (EUA) for antibody cocktail in India. It has also received a EUA in the US and several EU countries.

    These COVID-19 patients can get antibody cocktail as treatment

    The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older, weighing at least 40 kg) who are confirmed to be infected with SARS-CoV-2 infection. It can also be administered to patients who are at high risk of developing severe COVID-19 disease and do not require oxygen support.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Fortis Hospital
    Coronavirus

    Latest

    'Farzi' to 'Thunivu': Exciting OTT weekend watchlist is here OTT releases
    Here's how to come out of a toxic relationship  Relationships
    Lifeguards in Goa get AI assistance for rescue operations Goa
    Valentine's Week: 12 modern Bollywood romantic songs you cannot miss! Bollywood

    Fortis Hospital

    Delhi hospitals report cases of dehydration, vomiting amid rising mercury Delhi
    Two Delhi-NCR hospitals start administering Sputnik V; over 3K vaccinated Apollo Hospitals
    Activist compiles list of breast milk donors for motherless infants Coronavirus
    Be patient, you'll survive: Man, who defeated coronavirus, tells NewsBytes Rohit Sharma

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023